Compare Immunovant Inc. Common Stock (IMVT) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Nova Ltd — how do they compare? Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B), while Nova Ltd trades at $361.15 (market cap $11.28B). The key difference: Nova Ltd is the larger of the two by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Nova Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Nova Ltd for 5 Days on average.
| IMVT | NVMI | |
|---|---|---|
Market Cap | $6.25B | $11.28B |
Volume | 1,755,411 | 394,997 |
Sector | Health | Technology |
52-Week High | $44.96 | $605.65 |
52-Week Low | $17.03 | $275.78 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $5.35B | $11.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
